Kazia Therapeutics KZIA
NASDAQ KZIA
$8.03 -0.15 (-1.77%)
As of: Oct 22, 2026 · 2:09 PM EDT

Kazia Therapeutics (KZIA) Revenue (2009 - 2013)

Updated

Kazia Therapeutics' Revenue was $26,898 in the year ended Jun 30, 2025, down 98.2% from $1.51 million a year earlier.

Analysis

Kazia Therapeutics (KZIA) Revenue (2009 - 2013) Analysis & Trends

From the year ended Jun 30, 2009 onward, Kazia Therapeutics has reported Revenue for 13 years.

  • Revenue shows a four-year compound annual growth rate of -77.9% (years ended Jun 2021 to Jun 2025).
  • The figure for the year ended Jun 30, 2025 marks the lowest annual Revenue in data going back to the year ended Jun 30, 2009.
  • Per Business Quant data, Revenue in earlier years was $1.51 million in the year ended Jun 30, 2024 and $11.34 million in the year ended Jun 30, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,171.23 Bn 1,139.82 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 648.76 Bn 568.62 Bn 17.30 Bn 25.40 Bn
3 AbbVie 503.78 Bn 476.89 Bn 12.70 Bn 16.99 Bn
4 Merck 366.20 Bn 320.58 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 303.55 Bn 267.54 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 269.42 Bn 243.11 Bn 12.86 Bn 15.38 Bn
7 Amgen 242.43 Bn 197.83 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 195.01 Bn 169.21 Bn 6.22 Bn 7.80 Bn
9 Pfizer 172.42 Bn 119.07 Bn 10.94 Bn 15.03 Bn
10 Kazia Therapeutics 592,289.89 -51.78 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Aug 30, 2013 3.12 Mn
Dec 31, 2012 1.07 Mn
Dec 31, 2011 1.26 Mn
Dec 31, 2010 1.90 Mn
Jun 30, 2010 270,515.11
Dec 31, 2009 2.37 Mn
API Access

Kazia Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=KZIA&period=max&api_key=YOUR_API_KEY